Your browser doesn't support javascript.
loading
Iatrogenic cerebral amyloid angiopathy in older adults.
Panteleienko, Larysa; Mallon, Dermot; Oliver, Rupert; Toosy, Ahmed; Hoshino, Yuki; Murakami, Aya; Kaushik, Kanishk; Wermer, Marieke J H; Hara, Hideo; Yakushiji, Yusuke; Banerjee, Gargi; Werring, David J.
Afiliação
  • Panteleienko L; Department of Brain Repair and Rehabilitation, Stroke Research Centre, UCL Queen Square Institute of Neurology, London, UK.
  • Mallon D; Department of Neurology, Bogomolets National Medical University, Kyiv, Ukraine.
  • Oliver R; National Hospital for Neurology and Neurosurgery, Queen Square, University College London Hospitals NHS Foundation Trust, London, UK.
  • Toosy A; National Hospital for Neurology and Neurosurgery, Queen Square, University College London Hospitals NHS Foundation Trust, London, UK.
  • Hoshino Y; National Hospital for Neurology and Neurosurgery, Queen Square, University College London Hospitals NHS Foundation Trust, London, UK.
  • Murakami A; Department of Neuroinflammation, UCL Queen Square Institute of Neurology, London, UK.
  • Kaushik K; Division of Neurology, Department of Internal Medicine, Saga University Faculty of Medicine, Saga, Japan.
  • Wermer MJH; Department of Neurology Kansai Medical University, Hirakata, Japan.
  • Hara H; Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.
  • Yakushiji Y; Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.
  • Banerjee G; University Medical Centre Groningen, Groningen, The Netherlands.
  • Werring DJ; Division of Neurology, Department of Internal Medicine, Saga University Faculty of Medicine, Saga, Japan.
Eur J Neurol ; 31(6): e16278, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38511868
ABSTRACT
BACKGROUND AND

PURPOSE:

An increasing number of cases of iatrogenic cerebral amyloid angiopathy (CAA) have now been reported worldwide. Proposed diagnostic criteria require a history of medical intervention with potential for amyloidtransmission, for example those using cadaveric dura mater or requiring instrumentation of the brain or spinal cord. Clinical presentation occurs after an appropriate latency (usually three or four decades); to date, most patients with iatrogenic CAA have had 'early-onset' disease (compared to sporadic, age-related, CAA), as a consequence of childhood procedures.

RESULTS:

We describe five cases of possible iatrogenic CAA in adults presenting in later life (aged 65 years and older); all had prior neurosurgical interventions and presented after a latency suggestive of iatrogenic disease (range 30-39 years). Use of cadaveric dura mater was confirmed in one case, and highly likely in the remainder.

CONCLUSION:

The presentation of iatrogenic CAA in older adults widens the known potential spectrum of this disease and highlights the difficulties of making the diagnosis in this age group, and particularly in differentiating iatrogenic from sporadic CAA. Increased vigilance for cases presenting at an older age is essential for furthering our understanding of the clinical phenotype and broader implications of iatrogenic CAA.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Angiopatia Amiloide Cerebral / Doença Iatrogênica Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Eur J Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Angiopatia Amiloide Cerebral / Doença Iatrogênica Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Eur J Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido